Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion

Spine Journal

Volumn 14, Issue 6, 2014, Pages

  Christensen, Thomas J ^a   Annis, Prokopis ^a   Hohl, Justin B ^a   Patel, Alpesh A ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BMP 2; Chondrocyte metaplasia; Complication; Heterotopic bone; Radiculopathy; TLIF

Indexed keywords

INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; ECTOPIC TISSUE; FEMALE; FOLLOW UP; FORAMINOTOMY; HETEROTOPIC OSSIFICATION; HUMAN; LOW BACK PAIN; NERVE ROOT; NEUROFORAMINAL CHONDROCYTE METAPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; PARESTHESIA; PATIENT HISTORY OF SURGERY; PRIORITY JOURNAL; RADICULAR PAIN; RADICULOPATHY; RETROSPECTIVE STUDY; SPINAL CORD DECOMPRESSION; SPINE FUSION; VERTEBRAL CANAL STENOSIS; ADVERSE EFFECTS; CARTILAGE CELL; CHEMICALLY INDUCED; LUMBAR VERTEBRA; METAPLASIA; OFF LABEL DRUG USE; PATHOLOGY; PROCEDURES; RECURRENT DISEASE;

AGED; BONE MORPHOGENETIC PROTEIN 2; CHONDROCYTES; FEMALE; HUMANS; LOW BACK PAIN; LUMBAR VERTEBRAE; METAPLASIA; OFF-LABEL USE; OSSIFICATION, HETEROTOPIC; RECOMBINANT PROTEINS; RECURRENCE; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84901255951     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2013.11.028     Document Type: Article

References (30)

1. J. Burkus, M. Gornet, and T. Schuler et al. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2 J Bone Joint Surg Am 91 2009 1181 1189
2. S. Boden, T.A. Zdeblick, and H.S. Sandhu et al. The use of rhBMP-2 in interbody fusion cases Spine 25 2000 376 381
3. R. Haid, C. Branch, and J. Alexander et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages Spine J 4 2004 527 538
4. H. Meisel, M. Schnonring, and C. Hohaus et al. Posterior lumbar interbody fusion using rhBMP-2 Eur Spine J 17 2008 1735 1744
5. P. Mummaneni, J. Pan, and R. Haid et al. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report J Neurosurg Spine 1 2004 19 23
6. A. Shimer, F. Oner, and A. Vaccaro Spinal reconstruction and bone morphogenetic protein: open questions Injury 40 2009 S32 S38
7. P. Slosar, R. Josey, and J. Reynolds Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes Spine J 7 2007 301 307
8. S. Boden, J. Kang, and H. Sandhu et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans Spine 27 2002 2662 2673
9. K. Cahill, J. Chi, and A. Day et al. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures JAMA 302 2009 58 66
10. T. Mroz, J. Wang, and R. Hashimoto et al. Complications related to osteobiologics use in spine surgery Spine 35 2010 S86 S104
11. E. Carragee, E. Hurwitz, and B. Weiner A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned Spine J 11 2011 471 491
12. K. Ong, M. Villarraga, and E. Lau et al. Off-label use of bone morphogenetic proteins in the United States using administrative data Spine 35 2010 1794 1800
13. V. Joseph, and Y. Rampersaud Heterotopic bone formation with use of rhBMP2 in posterior minimal access interbody fusion Spine 32 2007 2885 2890
14. N. Chen, Z. Smith, and E. Stiner et al. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion J Neurosurg Spine 12 2010 40 46
15. J. Rihn, R. Patel, and J. Makda et al. Complications associated with single-level transforaminal lumbar interbody fusion Spine J 9 2009 623 629
16. D. Wong, A. Kumar, and S. Jatana et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2) Spine J 8 2008 1011 1018
17. J. McClellan, D. Mulconrey, and R. Forbes et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2) J Spinal Disord Tech 19 2006 483 486
18. R. Vaidya, A. Sethi, and S. Bartol et al. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions J Spinal Disord Tech 21 2008 557 562
19. S. Mindea, P. Shih, and J. Song Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions Spine 34 2009 1480 1484
20. R. Muchow, W. Hsu, and P. Anderson Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion Spine J 10 2010 e1 e6
21. S. Yoon, J. Park, and K. Kim et al. ISSLS prize winner LMP-1 upregulates disc cell production of proteoglycans and BMPs in vitro and in vivo Spine 29 2004 2603 2611
22. H. Zhang, D. Sucato, and R. Welch Recombinant human bone morphogenetic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thoracoscopically instrumented porcine model Spine 20 2005 512 518
23. A. Villavicencio, S. Burneikiene, and E. Nelson et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2 J Neurosurg Spine 3 2005 436 443
24. V. Patel, L. Zhao, and P. Wong et al. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue Spine 31 2006 1201 1206
25. T. Liu, Y. Gao, and K. Sakamoto et al. BMP-2 promotes differentiation of osteoblasts and chondrocytes in Runx2-deficient cell lines J Cell Phys 211 2007 728 735
26. J. Wozney, V. Rosen, and A.J. Celeste et al. Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528 1534
27. M. Takagi, N. Kamiya, and T. Takahashi et al. Effects of bone morphogenetic protein-2 and transforming growth factor B1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells J Mol Histol 35 2004 81 90
28. M. Houang, H. Merkur, and P. Russel Chondroid metaplasia of the peritoneum Pathology 42 2010 585 587
29. S. Lloyd, J. Lloyd, and R. Dhillon Chondroid metaplasia in a fibroepithelial polyp of the tongue J Laryngol Otol 115 2001 681 682
30. A. Jain, A. Rishi, and V. Suri et al. Recurrent ependymoma with cartilaginous metaplasia in an adult: report of a rare case and review of the literature Clin Neuropathol 28 2009 101 104